Matthew Brush

The issue here is not so much what 'endogenous' means on its own - which you have defined above. But how we are to interpreted an edge property called 'endogenous'...

We will add this to the set of use cases that are driving our ongoing discussion about qualifier and predicate semantics. The more such use cases we collect, the better...

FWIW, another way to think of these is as phenotypes associated with the disease. The HPO already phenotype terms representing altered levels of a specific chemical entity (e.g. [Hypocalcemia](https://hpo.jax.org/app/browse/term/HP:0002901) -...

@andrewsu i recall you mentioning on a call last month that Wikidata had developed a model to supporting track things like this (publications, databases, datasets where claims come from). Do...

Can someone clarify what we mean when we talk about 'conflation' in Translator? My understanding is that conflation as we have been debating in Translator occurs when two entities/nodes in...

Hi all. I want to revisit this decision to pre-compose anatomy-specific cell type classes in light of recent work toward capturing more statement semantics in qualifiers. One of the guiding...

Note that some of these predicates fall into the 'interaction mechanism' category, which the Chemical WG is working to harmonize. so work on these should be seeded to / coordinated...

Hi all. I don't have a deep understanding of the requirements/use cases related to provenance for SSSOM, but Chris' proposal above sounds reasonable. Cant make the workshop, but happy to...

@sebotic does chembl provide documentation/definitions for these terms that we can use/reference? Many are obvious, but some are not entirely clear w.r.t. their meaning (e.g. 'blocker'). Also, most of the...

One more thing - curious if you considered a design pattern where some or all of these properties are modeled as **roles/functions** inhering in the drug - rather than encoding...